Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
Final decision from the European Commission is anticipated within the coming months
Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR
In Q2 FY25, our crop protection segment reported revenue of Rs. 159 crore, with an EBIT margin of 5%
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market
Subscribe To Our Newsletter & Stay Updated
